Multi Commodity Exchange of India (MCX) shares soared to a record high after UBS increased its price target to ₹10,000, driven by a robust volume outlook and anticipated new product launches. UBS anticipates sustained strong trading volumes in key commodities, despite geopolitical uncertainties. The ‘Buy’ rating reflects confidence in MCX’s near- to medium-term growth prospects.
Ahead of Market: 10 things that will decide stock market action on Monday
Indian markets closed lower for the second straight week, dragged by weak earnings, US tariff threats, and global uncertainty. IT stocks underperformed while Glenmark Pharma